Max Healthcare Institute Ltd

- Max Healthcare reported 27% YoY growth in revenue and 23% growth in operating EBITDA in Q1 FY26, marking 19 consecutive quarters of YoY growth, indicating strong ongoing momentum. - Management expects continued EBITDA margin improvement in FY26, driven by better occupancy and utilization across hospitals, despite some margin pressures from superior clinical and payor mix. - EBITDA per bed and Return on Capital Employed (ROCE) are highlighted as more relevant metrics, expected to improve with new expansions and acquisitions. - New brownfield and greenfield bed capacities (~1,000 brownfield and 500 greenfield beds) are expected to start commissioning, further driving revenue and earnings growth. - Net debt is expected to increase modestly by Rs. 400-500 crores by FY26-end due to project funding, with Net Debt-to-EBITDA remaining under 1.0x, supporting financial stability for growth. - Acquisitions of lower ARPOB hospitals are targeted for strong ROCE (20-25%), contributing to overall profitable growth.

- Max Healthcare has several ongoing expansion projects contributing to its order book: - 400 beds at Zirakpur, Mohali: Approvals received; site work progressing; expected completion within 24 months. - 140 beds at Max Vaishali: Demolition underway; building plans being filed; expected completion within 30 months. - 500 beds at Thane: Master plan finalizing; detailed drawings being prepared; submissions starting by end of the quarter. - 250 beds at Pitampura, Delhi: Drawings submitted; site cleanup completed; construction to start upon approvals. - 268 beds at Nanavati Phase 1: Advanced commissioning stages. - 400 beds at Max Smart, Saket: Progressing; phased commissioning expected by end of Q2 FY '26. - Max Lucknow expansion: Increasing capacity from 413 to 520 beds by FY end. - 500 beds at Sector 56 Gurgaon: Structural work in progress; commissioning expected by FY end. - 100 beds at Max Nagpur: Environmental clearance awaited; project expected completion in 24 months. - 397 beds at Patparganj: Environmental clearance received; work in progress. - 550 beds at Max Vikrant, Saket: Awaiting Forest Dept clearance; project to start after Max Smart commissioning. - Net debt expected to increase by Rs. 400-500 crores by FY '26 related to these projects.

- Max Healthcare is actively expanding with ongoing and planned projects including: - 268 beds at Nanavati Phase 1, commissioning basements to third floors, starting soon. - 400 beds at Max Smart, Saket Complex, with phased commissioning expected by end Q2 FY '26. - Expansion at Max Lucknow to increase capacity from 413 to 520 beds by FY end. - 500 beds under construction at Sector 56 Gurgaon, expected commissioning by FY end. - 100 beds at Max Nagpur, awaiting environmental clearance; project to complete within 24 months. - 397 beds at Patparganj, environmental clearance received, construction underway. - 550 beds at Max Vikrant, Saket Complex, pending Forest Department clearance. - 400 beds at Zirakpur, Mohali under fast construction, expected completion in 24 months. - 140 beds expansion at Max Vaishali, demolition underway, completion in 30 months. - New 130-bed built-to-suit hospital in Dehradun, Board-approved lease agreement. - Rs. 435 crores deployed towards capacity expansions and upgrades in Q1 FY '26. - Rs. 131 crores spent on land purchase for brownfield expansion at Max Vaishali. - Net debt expected to rise by Rs. 400-500 crores by FY '26-end to fund projects, with Net debt-to-EBITDA <1.0x.

- Max Healthcare reported a strong 27% year-on-year revenue growth in Q1 FY '26, driven by successful hospital acquisitions and integrations. - Existing units showed a 16% revenue growth, with like-for-like ARPOB growth of 5% year-on-year. - Occupancy in base hospitals is around 80%, indicating capacity constraints; growth is expected from new bed additions. - Approximately 1,000 brownfield and 500 greenfield beds are expected to be commissioned in FY '26, driving volume growth. - New hospitals like Lucknow and Nagpur are contributing significantly, with Lucknow showing 97% revenue growth year-on-year. - Noida and Dwarka facilities are expected to see acceleration in performance post-integration. - International patient revenue grew by 32% year-on-year, bolstered by expanded marketing and new geographies. - Net debt poised to increase by Rs. 400-500 crores to support ongoing expansion, with manageable leverage (Net debt-to-EBITDA <1.0x). - Oncology segment expected to grow further, increasing its share in overall hospital revenue.

- No specific future fundraising through equity is mentioned in the transcript. - Regarding debt, the company expects net debt to increase by around Rs. 400-500 crores by the end of FY '26 to fund ongoing projects. - This anticipated increase in net debt is related to tied-up funds for expansion projects already underway. - Even with this increase, the net debt-to-EBITDA ratio is expected to remain below 1.0x, indicating a manageable leverage level. - There is no mention of any new fundraising plans via debt or equity beyond the above increase linked to project financing.